Tab Lasilactone - Key Information

What it contains

• Furosemide 20 mg + Spironolactone 50 mg per capsule (standard formulation)
• The 100:40 mg ratio (spironolactone:furosemide) is the evidence-based target ratio for fluid management

Indications (when to use it)

• Cirrhotic ascites (first-line combination per multiple guidelines)
• Heart failure with edema
• Nephrotic syndrome-related edema
• Resistant hypertension with fluid overload
• General peripheral edema where single-agent diuresis is inadequate

Dosage

Why the combination works well

• Furosemide causes potassium loss; spironolactone retains potassium - they balance each other out
• Spironolactone blocks aldosterone, which is often elevated in cirrhosis and heart failure (the main driver of fluid retention in these conditions)
• Combined effect is more powerful than either drug alone

Contraindications - do NOT give if:

• Anuria / severe renal failure (eGFR very low)
• Hyperkalemia (spironolactone raises potassium)
• Addison's disease
• Patient is already on ACE inhibitors + potassium supplements (high hyperkalemia risk)
• Pregnancy (spironolactone is anti-androgenic, teratogenic)

Monitor during therapy

• Serum electrolytes (especially K+, Na+) - check within 1 week of starting
• Renal function (creatinine, urea)
• Blood pressure
• Daily weight and urine output
• Target weight loss: ~0.5 kg/day in ascites without edema; up to 1 kg/day if peripheral edema also present

Note: The context (cirrhosis, heart failure, nephrotic syndrome, etc.) affects how you dose and titrate. If you share the clinical scenario, I can give more specific guidance.How can I help you? Feel free to ask anything!

Lasilactone for Pedal Edema + Moderate Ascites

Why it works here

• Moderate ascites with peripheral edema = significant sodium/fluid retention (usually cirrhosis or heart failure)
• Spironolactone blocks aldosterone, which is the main driver of sodium retention in cirrhosis
• Furosemide adds extra fluid removal and counters the potassium-sparing effect of spironolactone
• Together they maintain potassium balance better than either drug alone

Dosing Protocol (evidence-based)

• Spironolactone 100 mg/day + Furosemide 40 mg/day
• With Lasilactone (furo 20 mg + spiro 50 mg per capsule), this means 2 capsules once daily in the morning

Target weight loss

• Patient has both ascites AND edema - target 0.5 to 1 kg/day weight loss
• Check weight daily - faster loss risks acute kidney injury and hyponatremia

Before starting - check:

Monitor after starting:

• Electrolytes and creatinine at day 3-5, then weekly until stable
• Daily weight
• Urine output
• Signs of encephalopathy (if cirrhosis)

Stop or hold if:

• Serum Na+ < 125 mmol/L
• Serum K+ > 5.5 mmol/L (stop spironolactone)
• Creatinine rising sharply (AKI)
• Muscle cramps, confusion, severe hypotension

Diet advice alongside:

• Sodium restriction: < 2 g/day (88 mmol/day)
• No need to restrict fluid unless Na+ < 125

Sources: Sleisenger & Fordtran's GI and Liver Disease; Harrison's Principles of Internal Medicine 22E; Brenner & Rector's The Kidney

Lasilactone in Liver Cirrhosis with Pedal Edema + Moderate Ascites

Why Cirrhosis Causes Fluid Retention

1. Portal hypertension causes splanchnic vasodilation
2. Effective arterial blood volume drops
3. Body activates RAAS - aldosterone rises
4. Kidneys retain sodium and water - ascites and edema form
5. Spironolactone (in Lasilactone) directly blocks this aldosterone-driven sodium retention

Treatment Protocol for Grade 2 Ascites (Moderate)

• < 2 g sodium/day (80-120 mEq/day) - "no added salt" diet
• Avoid preprepared/packaged foods
• Do NOT severely restrict fluids unless serum Na+ < 130

Target Weight Loss

• Patient has ascites + edema: 0.5 to 1 kg/day
• Faster loss risks: AKI, hepatic encephalopathy, hyponatremia

Monitoring (Critical in Cirrhosis)

Stop Lasilactone and reassess if:

• Serum Na+ < 125 mmol/L
• Serum K+ > 5.5 mmol/L (stop spironolactone first)
• Creatinine rises > 100% or > 2 mg/dL (hepatorenal syndrome)
• Severe hepatic encephalopathy develops
• Marked muscle cramps

What if Lasilactone fails? (Refractory Ascites)

• Large-volume paracentesis (LVP) + IV albumin (8 g per litre removed)
• Consider TIPS (transjugular intrahepatic portosystemic shunt)
• Refer for liver transplant evaluation

Bottom line: For this cirrhosis patient with moderate ascites + pedal edema, start Lasilactone (2 caps = spiro 100 mg + furo 40 mg) once daily in the morning with sodium restriction. Titrate every 3-7 days targeting 0.5-1 kg/day weight loss. Monitor electrolytes and renal function closely.